Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.83), $0.18 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.